TCM
Tradition Capital Management Portfolio holdings
AUM
$369M
1-Year Return
6.73%
This Quarter Return
+1.21%
1 Year Return
+6.73%
3 Year Return
+43.57%
5 Year Return
+54.57%
10 Year Return
–
AUM
$352M
AUM Growth
+$2.63M
(+0.75%)
Cap. Flow
+$1.8M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
20.53%
Holding
180
New
10
Increased
51
Reduced
76
Closed
2
Top Buys
| 1 |
Colgate-Palmolive
CL
|
+$2.65M |
| 2 |
Ares Management
ARES
|
+$1.68M |
| 3 |
NXP Semiconductors
NXPI
|
+$1.56M |
| 4 |
AbbVie
ABBV
|
+$1.52M |
| 5 |
Citigroup
C
|
+$1.44M |
Top Sells
| 1 |
RSF
RiverNorth Capital and Income Fund
RSF
|
+$1.44M |
| 2 |
Microsoft
MSFT
|
+$1.36M |
| 3 |
Phillips 66
PSX
|
+$1.15M |
| 4 |
Devon Energy
DVN
|
+$1.12M |
| 5 |
Lowe's Companies
LOW
|
+$1.08M |
Sector Composition
| 1 | Financials | 18.41% |
| 2 | Healthcare | 17.35% |
| 3 | Technology | 12.71% |
| 4 | Consumer Discretionary | 8.77% |
| 5 | Industrials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boeing
BA
$163B
| $8.83M | 2.51% |
26,308
-165
| -0.6% | -$55.4K |
|
|
2
Microsoft
MSFT
$3.79T
| $8.22M | 2.33% |
83,331
-13,827
| -14% | -$1.36M |
|
3
Merck
MRK
$207B
| $8.14M | 2.31% |
140,486
-1,302
| -0.9% | -$75.4K |
|
|
4
AbbVie
ABBV
$386B
| $7.77M | 2.21% |
83,845
+16,441
| +24% | +$1.52M |
|
5
Qualcomm
QCOM
$175B
| $7.01M | 1.99% |
124,997
-975
| -0.8% | -$54.7K |
|
6
SPDR S&P 500 ETF Trust
SPY
$670B
| $6.99M | 1.99% |
25,779
+568
| +2% | +$154K |
|
7
JPMorgan Chase
JPM
$844B
| $6.84M | 1.94% |
65,676
-741
| -1% | -$77.2K |
|
|
8
Citigroup
C
$183B
| $6.43M | 1.83% |
96,055
+21,505
| +29% | +$1.44M |
|
9
Whirlpool
WHR
$5.15B
| $6.26M | 1.78% |
42,808
-782
| -2% | -$114K |
|
10
Citizens Financial Group
CFG
$22.4B
| $5.84M | 1.66% |
150,037
+2,950
| +2% | +$115K |
|
11
3M
MMM
$84.1B
| $5.72M | 1.62% |
34,768
-191
| -0.5% | -$31.4K |
|
12
Medtronic
MDT
$121B
| $5.57M | 1.58% |
65,053
-1,635
| -2% | -$140K |
|
13
Marsh & McLennan
MMC
$99.8B
| $5.54M | 1.57% |
67,581
-11,830
| -15% | -$970K |
|
14
IBM
IBM
$236B
| $5.5M | 1.56% |
41,179
+3,367
| +9% | +$450K |
|
15
Bristol-Myers Squibb
BMY
$94B
| $5.46M | 1.55% |
98,740
+5,283
| +6% | +$292K |
|
16
Novartis
NVS
$240B
| $5.37M | 1.52% |
79,334
-943
| -1% | -$63.8K |
|
17
Willis Towers Watson
WTW
$33B
| $5.34M | 1.52% |
35,232
-185
| -0.5% | -$28K |
|
18
Hanesbrands
HBI
$2.2B
| $5.3M | 1.51% |
240,824
-6,490
| -3% | -$143K |
|
19
Johnson & Johnson
JNJ
$429B
| $5.21M | 1.48% |
42,900
+1,350
| +3% | +$164K |
|
20
Intel
INTC
$112B
| $5.17M | 1.47% |
104,064
-188
| -0.2% | -$9.35K |
|
21
Avery Dennison
AVY
$12.9B
| $4.8M | 1.36% |
46,979
+327
| +0.7% | +$33.4K |
|
22
Abbott
ABT
$233B
| $4.76M | 1.35% |
77,990
-3,310
| -4% | -$202K |
|
23
Apple
AAPL
$3.47T
| $4.63M | 1.31% |
100,072
+1,612
| +2% | +$74.6K |
|
24
Everest Group
EG
$14.7B
| $4.56M | 1.3% |
19,802
+280
| +1% | +$64.5K |
|
25
Thermo Fisher Scientific
TMO
$181B
| $4.45M | 1.26% |
21,482
-730
| -3% | -$151K |
|